CTIC-DD) Market Cap $97 Million / Cash $81 Million or enough untill Q1 2022 / 2 Phase 3 Gems including Covid 19 Drug with Phase 3 results coming later this year / Strong Institutional ownership = Could run to $10++ and more very attractive Invesmtent here .STRONG BUY and GL Cti Biopharma (CTIC) Market Cap:$97 Million Cash: $81 Million Price: $1.34 Shares Out: 73.7 Million Presentation https://cbc.gcs-web.com/static-files/83278a88-ff8f-457a-bccf-1900fe5042d8 CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial https://finance.yahoo.com/news/cti-biopharma-announces-enrollment-first-110000668.html - Company Expects to Report Topline Data by the End of 2020 - Largest Shareholder : OrbiMed ...9.5M New Enterprise ...7.1M BVF Partners L.P...6.9M Stonepine ...6.4M Medical Strategy ...2.3M The Vanguard ...2.1M Renaissance ...2.1M BlackRock ...753.3K Caxton Associates LP...616.7K Geode Capital ...416.0K
